JP2019504623A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019504623A5 JP2019504623A5 JP2018538841A JP2018538841A JP2019504623A5 JP 2019504623 A5 JP2019504623 A5 JP 2019504623A5 JP 2018538841 A JP2018538841 A JP 2018538841A JP 2018538841 A JP2018538841 A JP 2018538841A JP 2019504623 A5 JP2019504623 A5 JP 2019504623A5
- Authority
- JP
- Japan
- Prior art keywords
- vaccine
- mastitis
- prevention
- treatment
- infection caused
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229960005486 vaccine Drugs 0.000 claims 13
- 208000015181 infectious disease Diseases 0.000 claims 8
- 208000004396 mastitis Diseases 0.000 claims 8
- 230000002265 prevention Effects 0.000 claims 8
- 239000003795 chemical substances by application Substances 0.000 claims 6
- 230000002163 immunogen Effects 0.000 claims 6
- 241000194017 Streptococcus Species 0.000 claims 5
- 239000002253 acid Substances 0.000 claims 4
- 238000000034 method Methods 0.000 claims 4
- 239000008194 pharmaceutical composition Substances 0.000 claims 4
- 241000894006 Bacteria Species 0.000 claims 3
- 238000010438 heat treatment Methods 0.000 claims 3
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 claims 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims 2
- 229920002307 Dextran Polymers 0.000 claims 2
- 239000002671 adjuvant Substances 0.000 claims 2
- 229940035032 monophosphoryl lipid a Drugs 0.000 claims 2
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 claims 1
- 108010042708 Acetylmuramyl-Alanyl-Isoglutamine Proteins 0.000 claims 1
- 241000208340 Araliaceae Species 0.000 claims 1
- 229920001503 Glucan Polymers 0.000 claims 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims 1
- 235000003140 Panax quinquefolius Nutrition 0.000 claims 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 claims 1
- 229930003427 Vitamin E Natural products 0.000 claims 1
- 229920000392 Zymosan Polymers 0.000 claims 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 claims 1
- ILRRQNADMUWWFW-UHFFFAOYSA-K aluminium phosphate Chemical compound O1[Al]2OP1(=O)O2 ILRRQNADMUWWFW-UHFFFAOYSA-K 0.000 claims 1
- 229910002092 carbon dioxide Inorganic materials 0.000 claims 1
- 239000001569 carbon dioxide Substances 0.000 claims 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims 1
- 235000008434 ginseng Nutrition 0.000 claims 1
- 238000011534 incubation Methods 0.000 claims 1
- 238000007918 intramuscular administration Methods 0.000 claims 1
- 238000007912 intraperitoneal administration Methods 0.000 claims 1
- 238000001990 intravenous administration Methods 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- BSOQXXWZTUDTEL-ZUYCGGNHSA-N muramyl dipeptide Chemical compound OC(=O)CC[C@H](C(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](C)O[C@H]1[C@H](O)[C@@H](CO)O[C@@H](O)[C@@H]1NC(C)=O BSOQXXWZTUDTEL-ZUYCGGNHSA-N 0.000 claims 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 claims 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 claims 1
- 229920000642 polymer Polymers 0.000 claims 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 claims 1
- 229930182490 saponin Natural products 0.000 claims 1
- 150000007949 saponins Chemical class 0.000 claims 1
- 229940032094 squalane Drugs 0.000 claims 1
- 229940031439 squalene Drugs 0.000 claims 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 claims 1
- 238000007920 subcutaneous administration Methods 0.000 claims 1
- 238000002255 vaccination Methods 0.000 claims 1
- 229940046009 vitamin E Drugs 0.000 claims 1
- 235000019165 vitamin E Nutrition 0.000 claims 1
- 239000011709 vitamin E Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16382060 | 2016-02-15 | ||
| EP16382060.8 | 2016-02-15 | ||
| PCT/EP2017/053306 WO2017140683A2 (en) | 2016-02-15 | 2017-02-14 | Streptococcus uberis extract as an immunogenic agent |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019504623A JP2019504623A (ja) | 2019-02-21 |
| JP2019504623A5 true JP2019504623A5 (https=) | 2020-03-26 |
| JP6839199B2 JP6839199B2 (ja) | 2021-03-03 |
Family
ID=55646514
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018538841A Active JP6839199B2 (ja) | 2016-02-15 | 2017-02-14 | 免疫原性剤としてのストレプトコッカス・ウベリス抽出物 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US10946085B2 (https=) |
| EP (1) | EP3417049B1 (https=) |
| JP (1) | JP6839199B2 (https=) |
| KR (1) | KR102824686B1 (https=) |
| AU (1) | AU2017220528A1 (https=) |
| CA (1) | CA3012419A1 (https=) |
| ES (1) | ES2960326T3 (https=) |
| MX (1) | MX387200B (https=) |
| PL (1) | PL3417049T3 (https=) |
| WO (1) | WO2017140683A2 (https=) |
| ZA (1) | ZA201805039B (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4406551A4 (en) | 2021-09-21 | 2025-10-08 | Nat Agriculture & Food Res Org | VACCINE COMPRISING A NON-ENCAPSULATED STRAIN AS ANTIGEN |
| EP4570265A1 (en) | 2023-12-15 | 2025-06-18 | Zaklad Badawczo-Wdrozeniowy Osrodka Salmonella "Immunolab" Sp. z o.o. | Vaccine for use in preventing inflammatory conditions in cows |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS60243024A (ja) * | 1983-12-29 | 1985-12-03 | Kitasato Inst:The | ストレプトコツカス・サンギス感染症予防用ワクチン，診断用抗原および抗体 |
| CA2059693C (en) * | 1991-01-28 | 2003-08-19 | Peter J. Kniskern | Polysaccharide antigens from streptococcus pneumoniae |
| WO1996041879A1 (en) | 1995-06-08 | 1996-12-27 | University Of Saskatchewan | Camp factor of streptococcus uberis |
| ES2273861T3 (es) | 2000-06-12 | 2007-05-16 | University Of Saskatchewan | Inmunizacion de ganado vacuno lechero con proteina gapc frente a infecciones por streptococcus. |
| US20070231335A1 (en) * | 2005-07-20 | 2007-10-04 | Bruce Beutler | Compositions and methods for treating Gram positive bacterial infection in a mammalian subject |
| PL2068918T5 (pl) | 2006-09-26 | 2024-12-02 | Access To Advanced Health Institute | Kompozycja szczepionki zawierająca syntetyczny adiuwant |
| US20110028407A1 (en) * | 2007-02-09 | 2011-02-03 | Jutila Mark A | Enhancement of innate resistance to infection |
| GB0818231D0 (en) | 2008-10-06 | 2008-11-12 | Univ Nottingham | Composition |
| SG10201406432RA (en) * | 2009-06-22 | 2014-11-27 | Wyeth Llc | Compositions and methods for preparing staphylococcus aureus serotype 5 and 8 capsular polysaccharide conjugate immunogenic compositions |
| AU2012222827A1 (en) * | 2011-03-03 | 2013-10-03 | The Governors Of The University Of Alberta | Use of bacterial endotoxins and lipoteichoic acids to improve postpartal health and productivity of dairy cows and their newborns |
| US20140088032A1 (en) * | 2011-05-12 | 2014-03-27 | Thomas Simon Ilg | Treatment of mastitis |
| BR112013032675A2 (pt) * | 2011-06-19 | 2017-08-08 | Vaxine Pty Ltd | composição adjuvante de vacina compreendendo partículas de inulina |
| UA130246C2 (uk) | 2013-09-19 | 2025-12-31 | Зоетіс Сервісіз Ллс | Ад'ювант на основі олії |
-
2017
- 2017-02-14 EP EP17704038.3A patent/EP3417049B1/en active Active
- 2017-02-14 PL PL17704038.3T patent/PL3417049T3/pl unknown
- 2017-02-14 JP JP2018538841A patent/JP6839199B2/ja active Active
- 2017-02-14 WO PCT/EP2017/053306 patent/WO2017140683A2/en not_active Ceased
- 2017-02-14 KR KR1020187021575A patent/KR102824686B1/ko active Active
- 2017-02-14 ES ES17704038T patent/ES2960326T3/es active Active
- 2017-02-14 CA CA3012419A patent/CA3012419A1/en active Pending
- 2017-02-14 MX MX2018009048A patent/MX387200B/es unknown
- 2017-02-14 US US16/075,092 patent/US10946085B2/en active Active
- 2017-02-14 AU AU2017220528A patent/AU2017220528A1/en not_active Abandoned
-
2018
- 2018-07-26 ZA ZA2018/05039A patent/ZA201805039B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2605834C2 (ru) | Поливалентная композиция, содержащая конъюгаты пневмококковый полисахарид-белок | |
| PH12017501898A1 (en) | Group b streptococcus polysaccharide-protein conjugates, methods for producing conjugates, immunogenic compositions comprising conjugates, and uses thereof | |
| HRP20221438T1 (hr) | Postupak glikokonjugiranja | |
| WO2014009971A3 (en) | Non-alcoholic vaccine compositions free from animal- origin and process for preparation thereof | |
| CN110520154B (zh) | 多价肺炎链球菌疫苗组合物 | |
| JP2012006969A5 (https=) | ||
| PE20211888A1 (es) | Composiciones que comprenden conjugados de polisacarido de streptococcus pneumoniae con proteina y sus metodos de uso | |
| BR112018007812A2 (pt) | polissacarídeo capsular, processo para preparar um polissacarídeo capsular e para fabricar uma vacina, composição imunogênica, vacina, métodos para tratamento ou prevenção de uma infecção, para imunizar um hospedeiro humano e para induzir uma resposta imune, e, uso de uma composição imunogênica. | |
| EP4649956A3 (en) | Immunogenic compositions comprising conjugated capsular saccharide antigens, kits comprising the same and uses thereof | |
| RU2017145963A (ru) | Составы вакцин против неоплазии и способы их получения | |
| RU2016127123A (ru) | Капсульные полисахариды Streptococcus pneumoniae и их конъюгаты | |
| JP2016503015A (ja) | 多価肺炎球菌多糖類−タンパク質接合体組成物 | |
| JP6882193B2 (ja) | 微生物莢膜多糖類からタンパク質および他の不純物を分離するための方法 | |
| JP2022130637A5 (https=) | ||
| CA2618306A1 (en) | Inactivating pathogens with hydrogen peroxide for vaccine production | |
| JP2011506334A5 (https=) | ||
| BR112023021812A2 (pt) | Composição vacinal adjuvantada e métodos | |
| JP2019504623A5 (https=) | ||
| JP2019509300A5 (https=) | ||
| WO2018042017A3 (en) | Vaccines for neisseria gonorrhoeae | |
| RU2480237C1 (ru) | Ассоциированная вакцина для профилактики сибирской язвы и некробактериоза животных | |
| JP2015091795A (ja) | 鼻粘膜ワクチン組成物 | |
| WO2024261351A3 (en) | Immunologically active saponin fractions and adjuvant formulations | |
| RU2014147491A (ru) | Антигены и антигенные композиции | |
| WO2017140683A3 (en) | Streptococcus uberis extract as an immunogenic agent |